13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gene expression profiling of depression and suicide in human prefrontal cortex.

      Neuropsychopharmacology
      Adult, Aged, Case-Control Studies, Computational Biology, methods, Depression, complications, genetics, Female, Gene Expression, Gene Expression Profiling, Humans, Male, Middle Aged, Prefrontal Cortex, metabolism, Protein-Tyrosine Kinases, Psychiatric Status Rating Scales, RNA, Messenger, Receptor, Fibroblast Growth Factor, Type 3, Receptor, Serotonin, 5-HT1A, Receptor, Serotonin, 5-HT2A, Receptor, trkB, Receptors, Fibroblast Growth Factor, Reverse Transcriptase Polymerase Chain Reaction, Suicide

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mood disorders are a major cause of disability. Etiology includes genetic and environmental factors, but the responsible genes have yet to be identified. Using DNA microarrays, we have conducted a large-scale gene expression analysis, in two regions of the human prefrontal cortex from post-mortem matched groups of subjects with major depression who had died by suicide, and control subjects who died from other causes and were free from psychiatric disorders. Bioinformatic analysis was used to investigate molecular and cellular pathways potentially involved in depression and suicidal behavior. We tested several hypotheses of disease pathology and of their putative molecular impact, including changes in single genes, the existence of subgroups of patients or disease subtypes, or the possibility of common biological pathways being affected in the disease process. Within the analytical limits of this relatively large genomic study, we found no evidence for molecular differences that correlated with depression and suicide, suggesting a pathology that is below the detection level of current genomic approaches, or that is either localized to other brain areas, or more associated with post-transcriptional effects and/or changes in protein levels or functions, rather than altered transcriptome in the prefrontal cortex.

          Related collections

          Author and article information

          Comments

          Comment on this article